NUR 218 Final Practice Questions
Save
Terms in this set (50)
The nurse is using data A
collected to set goals or
expected outcomes and
interventions that address
the patient's problems.
Which step of the nursing
process is the nurse
applying?
A. Planning
B. Assessment
C.Diagnosis
D. Evaluation
,The nurse is preparing to C
administer a medication
and reviews the patient's
chart for drug allergies,
serum creatinine, and
blood urea nitrogen
(BUN) levels. The nurse's
actions are reflective of
which phase of the
nursing process?
A. Evaluation
B. Planning
C. Assessment
D. Implementation
Which law(s) govern all A
drug administration by
nurses?
A. Nurse Practice Acts
B. Drug Regulation and
Reform Act
C. FDA Amendments Act
D. The Controlled
Substances Act
The nurse gives a highly D
metabolized medication
to a patient with a history
of liver disease. What will
the nurse will monitor for
this patient?
A. Increased therapeutic
range
B. Decreased therapeutic
range
C. Decreased drug
effects.
D. Increased drug effects.
,A patient has been taking C
a drug for several years
and tells the nurse it is no
longer working. The nurse
learns that the patient has
recently begun taking an
over-the-counter (OTC)
antacid medication. What
does the nurse suspect is
occurring?
A. Drug tolerance
B. An adverse drug
reaction
C. A drug interaction
D. Drug incompatibility
There are many legal and B
ethical issues related to
pharmacogenomics.
Which of the following are
questions NOT related to
privacy?
A. Who owns the genetic
information?
B. All patients cannot
afford pharmacogenetic
testing.
C. Who has access to
patient genetic
information?
D. Concerns about patient
"labeling" based on
genetic code.
, The nurse is preparing to B
administer a medication to
a 6-month-old infant. The
nurse will monitor closely
for signs of drug toxicity
based on the knowledge
that, compared to adults,
infants have:
A. more rapid
gastrointestinal transit
time.
B. immature hepatic and
renal function.
C. more protein binding
sites.
D. an increased
percentage of total body
fat.
Save
Terms in this set (50)
The nurse is using data A
collected to set goals or
expected outcomes and
interventions that address
the patient's problems.
Which step of the nursing
process is the nurse
applying?
A. Planning
B. Assessment
C.Diagnosis
D. Evaluation
,The nurse is preparing to C
administer a medication
and reviews the patient's
chart for drug allergies,
serum creatinine, and
blood urea nitrogen
(BUN) levels. The nurse's
actions are reflective of
which phase of the
nursing process?
A. Evaluation
B. Planning
C. Assessment
D. Implementation
Which law(s) govern all A
drug administration by
nurses?
A. Nurse Practice Acts
B. Drug Regulation and
Reform Act
C. FDA Amendments Act
D. The Controlled
Substances Act
The nurse gives a highly D
metabolized medication
to a patient with a history
of liver disease. What will
the nurse will monitor for
this patient?
A. Increased therapeutic
range
B. Decreased therapeutic
range
C. Decreased drug
effects.
D. Increased drug effects.
,A patient has been taking C
a drug for several years
and tells the nurse it is no
longer working. The nurse
learns that the patient has
recently begun taking an
over-the-counter (OTC)
antacid medication. What
does the nurse suspect is
occurring?
A. Drug tolerance
B. An adverse drug
reaction
C. A drug interaction
D. Drug incompatibility
There are many legal and B
ethical issues related to
pharmacogenomics.
Which of the following are
questions NOT related to
privacy?
A. Who owns the genetic
information?
B. All patients cannot
afford pharmacogenetic
testing.
C. Who has access to
patient genetic
information?
D. Concerns about patient
"labeling" based on
genetic code.
, The nurse is preparing to B
administer a medication to
a 6-month-old infant. The
nurse will monitor closely
for signs of drug toxicity
based on the knowledge
that, compared to adults,
infants have:
A. more rapid
gastrointestinal transit
time.
B. immature hepatic and
renal function.
C. more protein binding
sites.
D. an increased
percentage of total body
fat.
